The results suggest that, irrespective of cancer types, toptecan sensitivity is generally associated with Top1 (p-value = 7.7e-03) and WRN (p-value = 2.27e-06) mRNA expression (Supplementary Figure S5a, S5b and 5c). Here, TOP1 is linked to cancer.